• New perspectives in cardio-vascular disease approach

  • Glycaemic variability, Oxidative Stress and CV Damage in Diabetes – impact on cardiovascular risk

  • CV risk management in type 2 diabetes – new strategies

  • New perspectives in cardiovascular disease in patients with type 2 diabetes – Heart failure and antidiabetic therapy

  • Insulins in Diabetes-how long, how fast?

  • New therapies in type 2 diabetes – moving beyond HbA1c and going to organ protection

  • Outcomes Trial Results: importance for Type 2 diabetes management

  • Poster presentations